Literature DB >> 12457212

Laparoscopic revision of failed open bariatric procedures.

J T McCormick1, P K Papasavas, P F Caushaj, D J Gagné.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) is considered the surgical procedure of choice for morbid obesity. Patients who fail to meet weight loss goals after restrictive or malabsorptive surgery can be offered revision. We present five cases in which prior open bariatric procedures were revised laparoscopically. PATIENTS: Five patients presented for laparoscopic revision having regained weight after initial success with prior bariatric surgery.
RESULTS: Preoperative body mass index averaged 46 kg/m2. Average operative time was significantly longer (344 min) than we had experienced with 56 primary RYGB during the same 4-month period (206 min). In one patient, a stricture had developed at the gastrojejunostomy requiring endoscopic dilation. There were no other complications and no deaths. All the patients had lost weight at the 6-month follow-up assessment.
CONCLUSIONS: Laparoscopic revision of failed open bariatric procedures, although requiring longer operative times than primary RYGB, can be performed safely in the hands of an experienced minimally invasive surgeon.

Entities:  

Mesh:

Year:  2002        PMID: 12457212     DOI: 10.1007/s00464-002-8533-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  14 in total

1.  Reoperation following minimally invasive surgery: are the "rules" different?

Authors:  James T McCormick; Clifford L Simmang
Journal:  Clin Colon Rectal Surg       Date:  2006-11

2.  Reasons and outcomes of reoperative bariatric surgery for failed and complicated procedures (excluding adjustable gastric banding).

Authors:  Sheetal Patel; Samuel Szomstein; Raul J Rosenthal
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

Review 3.  Current status of endoluminal bariatric procedures for primary and revision indications.

Authors:  Marvin Ryou; Michele B Ryan; Christopher C Thompson
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-04

4.  Endoscopic gastrojejunostomy revision is more effective than medical management alone to address weight regain after RYGB.

Authors:  H Mason Hedberg; Alexander Trenk; Kristine Kuchta; John G Linn; JoAnn Carbray; Michael B Ujiki
Journal:  Surg Endosc       Date:  2018-01-24       Impact factor: 4.584

5.  Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain.

Authors:  C C Thompson; J Slattery; M E Bundga; D B Lautz
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

6.  Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008.

Authors:  Mathias Worni; Ulrich Guller; Anand Shah; Mihir Gandhi; Jatin Shah; Dimple Rajgor; Ricardo Pietrobon; Danny O Jacobs; Truls Ostbye
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

Review 7.  Endoscopic Treatments Following Bariatric Surgery.

Authors:  Andrew C Storm; Christopher C Thompson
Journal:  Gastrointest Endosc Clin N Am       Date:  2017-04

8.  Laparoscopic conversion of vertical banded gastroplasty with an antireflux wrap into Roux-en-Y gastric bypass.

Authors:  Antonio Iannelli; Pietro Addeo; Moucef Dahman; Massimo Senni Buratti; Imed Ben Amor; Thierry Piche; Jean Gugenheim
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

9.  Laparoscopic reversal of Roux-en-Y gastric bypass into normal anatomy with or without sleeve gastrectomy.

Authors:  Ramon Vilallonga; Simon van de Vrande; Jacques Himpens
Journal:  Surg Endosc       Date:  2013-07-17       Impact factor: 4.584

10.  Conversion of vertical banded gastroplasty to Roux-en-Y gastric bypass results in restoration of the positive effect on weight loss and co-morbidities: evaluation of 101 patients.

Authors:  Ruben Schouten; Francois M H van Dielen; Wim G van Gemert; Jan Willem M Greve
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.